Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
22.74
-0.10 (-0.44%)
Jan 22, 2025, 11:49 AM EST - Market open
Pacira BioSciences Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$27.60
Upside
+21.37%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $18 | Hold | Reiterates | $18 | -20.84% | Jan 14, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +31.93% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +31.93% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +71.50% | Dec 4, 2024 |
| Barclays | Barclays | Hold Maintains $25 → $17 | Hold | Maintains | $25 → $17 | -25.24% | Nov 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | -3.25% | Nov 8, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | -29.64% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $14 → $15 | Hold | Maintains | $14 → $15 | -34.04% | Oct 4, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | -20.84% | Sep 24, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Strong Sell Downgrades $30 → $8 | Strong Buy → Strong Sell | Downgrades | $30 → $8 | -64.82% | Aug 13, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $37 → $14 | Buy → Hold | Downgrades | $37 → $14 | -38.43% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $39 | Strong Buy | Maintains | $57 → $39 | +71.50% | Aug 12, 2024 |
| Needham | Needham | Strong Buy Maintains $43 → $22 | Strong Buy | Maintains | $43 → $22 | -3.25% | Aug 12, 2024 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades $45 → $10 | Buy → Sell | Downgrades | $45 → $10 | -56.02% | Aug 12, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $36 → $30 | Strong Buy | Maintains | $36 → $30 | +31.93% | Aug 1, 2024 |
| Raymond James | Raymond James | Buy Maintains $41 → $37 | Buy | Maintains | $41 → $37 | +62.71% | Jul 31, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.